Sitagliptin Phosphate Tablets 25 mg, 50 mg, 100 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 25 mg, 50 mg, 100 mg
Reference Brands: Januvia(US & EU)
Category: Diabetes
Sitagliptin is a DPP-4 inhibitor that enhances incretin levels, increasing insulin release and decreasing glucagon secretion in a glucose-dependent manner. This improves glycemic control without causing hypoglycemia. It’s weight-neutral, well-tolerated, and effective as monotherapy or in combination therapy for Type 2 diabetes, supporting long-term blood sugar regulation.
Product Description:
Sitagliptin, marketed under the brand name Januvia, is a DPP-4 inhibitor approved for managing type 2 diabetes mellitus. In the USA, the FDA approved Sitagliptin in 2006, and it remains under brand protection with limited generic availability. In the EU, it received EMA approval in 2007 and is available in multiple strengths (25 mg, 50 mg, 100 mg). Sitagliptin is used as monotherapy or in combination with other antidiabetic agents. Pharmacovigilance data confirms a favorable safety profile. With patent expirations approaching in some regions, generic versions are beginning to enter select EU markets. Widely sourced via platforms like Pharmatradz.com.
Sitagliptin Phosphate Tablets — third party manufacturing & bulk supply
Sitagliptin Phosphate Tablets 25 mg, 50 mg, 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Sitagliptin Phosphate Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Sitagliptin Phosphate Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Sitagliptin Phosphate tablets are used to control blood sugar levels in patients with type 2 diabetes mellitus. They help improve glycemic control by increasing insulin release and decreasing glucose production, especially when used along with diet and exercise.
These tablets are made from sitagliptin phosphate monohydrate, a DPP-4 (dipeptidyl peptidase-4) inhibitor that works by increasing incretin hormones, which help regulate blood sugar by enhancing insulin secretion and reducing glucagon levels.
Common trade names include Januvia (USA, EU, UK), Xelevia (EU), Tesavel (EU), Sitagliptin (generic brands), and various regional brands available in India and LATAM markets.
The original product is developed and marketed by Merck & Co., Inc. (MSD). It is also manufactured by multiple pharmaceutical companies worldwide, including Sun Pharma, Cipla, Lupin, Dr. Reddy’s Laboratories, and other generic manufacturers.
The complete generic name is sitagliptin phosphate monohydrate.
Brand names include Januvia, Xelevia, Tesavel, and various country-specific generic brands.
Sitagliptin Phosphate tablets are manufactured globally in countries such as the USA, UK, EU nations, India, and LATAM regions by both innovator and generic pharmaceutical companies.
Related Products
Pioglitazone Hydrochloride 150Mg Tablet
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
